04.07.2023 STRATEC SE  DE000STRA555

EQS-News: STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS


 

EQS-News: STRATEC SE / Key word(s): Mergers & Acquisitions
STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS

04.07.2023 / 12:13 CET/CEST
The issuer is solely responsible for the content of this announcement.


STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS

Birkenfeld, July 4, 2023

STRATEC SE, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, SDAX) can today announce the successful completion of the acquisition of Natech Plastics, Inc. (hereinafter: “Natech”), based in Ronkonkoma, NY/USA as of July 1, 2023. This follows on the agreement to fully acquire the company, which was communicated on June 7, 2023.

Natech designs and manufactures smart polymer-based consumables for customers in medical technology, in-vitro diagnostics, life sciences, consumer goods, and specialist packaging solutions. The company also has state-of-the-art production capacities for injection molding and assembly, including clean room production.

ABOUT STRATEC
STRATEC SE (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and life sciences. Furthermore, the company offers complex consumables for diagnostic and medical applications. For its analyzer systems and consumables, STRATEC covers the entire value chain – from development to design and production through to quality assurance.

The partners market the systems, software, and consumables in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of patented technologies.

Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the SDAX select index of the German Stock Exchange.

FURTHER INFORMATION IS AVAILABLE FROM:
STRATEC SE
Jan Keppeler | Investor Relations, Sustainability & Corporate Communications
Tel: +49 7082 7916-6515
[email protected]
www.stratec.com



04.07.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: STRATEC SE
Gewerbestr. 37
75217 Birkenfeld
Germany
Phone: +49 (0)7082 7916 0
Fax: +49 (0)7082 7916 999
E-mail: [email protected]
Internet: www.stratec.com
ISIN: DE000STRA555
WKN: STRA55
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1672305

 
End of News EQS News Service

1672305  04.07.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1672305&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 209,76 187,82 214,16 250,10 287,34 274,63 261,91
EBITDA1,2 47,33 35,53 35,60 56,27 66,43 58,07 40,08
EBITDA-Marge3 22,56 18,92 16,62 22,50 23,12 21,14
EBIT1,4 28,84 15,01 17,19 33,68 48,18 41,14 22,39
EBIT-Marge5 13,75 7,99 8,03 13,47 16,77 14,98 8,55
Jahresüberschuss1 25,64 8,97 14,41 25,18 39,96 29,22 13,07
Netto-Marge6 12,22 4,78 6,73 10,07 13,91 10,64 4,99
Cashflow1,7 29,98 11,95 21,26 31,85 63,47 10,28 19,43
Ergebnis je Aktie8 2,22 0,75 1,20 2,07 3,28 2,41 1,07
Dividende8 0,80 0,82 0,84 0,90 0,95 0,97 0,77
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: RSM Ebner Stolz

INVESTOR-INFORMATIONEN
©boersengefluester.de
Stratec
WKN Kurs in € Einschätzung Börsenwert in Mio. €
STRA55 42,850 Halten 520,96
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
25,21 34,89 0,73 24,24
KBV KCV KUV EV/EBITDA
2,30 26,82 1,99 16,05
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,97 0,55 1,28 17.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
26.04.2024 09.08.2024 25.10.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,07% -2,06% -5,93% -31,55%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu STRATEC SE  ISIN: DE000STRA555 können Sie bei EQS abrufen


Medtech , STRA55 , SBS , XETR:SBS